Xiao, F. ., W. . Xiao, X. Li, R. . Li, and K. . Zhao. “Cost-Effectiveness Analysis of Trastuzumab Deruxtecan As Second-Line Treatment for HER2- Positive Advanced Breast Cancer”. Health Decision, vol. 2, no. S1, July 2024, doi:10.54844/hd.2024.0009.